Company bioAffinity Technologies, Inc.
Equities
BIAF
US09076W1099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.18 USD | -1.36% | -7.23% | +48.25% |
May. 15 | BioAffinity Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $2.4M | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Laboratory Services
99.2
%
| - | - | 3 | 99.2 % | - |
Diagnostic Research and Development
0.8
%
| - | - | 0 | 0.8 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 3 | 100.0 % | +52,627.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Maria Zannes
FOU | Founder | 68 | 14-03-25 |
Director of Finance/CFO | 45 | 23-04-30 | |
David Elzi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Vivienne Rebel
CTO | Chief Tech/Sci/R&D Officer | 59 | 15-12-31 |
Xavier Reveles
COO | Chief Operating Officer | 55 | 16-12-31 |
Julie Overton
IRC | Investor Relations Contact | - | 23-02-12 |
Dallas Coleman
SAM | Sales & Marketing | - | Nov. 05 |
William Bauta
PRN | Corporate Officer/Principal | - | - |
Jennifer Rebeles
PRN | Corporate Officer/Principal | - | 18-12-31 |
Timothy Zannes
LAW | General Counsel | 72 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Girgenti
CHM | Chairman | 78 | 14-02-28 |
Peter Knight
BRD | Director/Board Member | 73 | 18-04-30 |
Stuart Diamond
BRD | Director/Board Member | 63 | 21-12-31 |
Maria Zannes
FOU | Founder | 68 | 14-03-25 |
Robert Anderson
BRD | Director/Board Member | 84 | 14-03-31 |
Gary Rubin
BRD | Director/Board Member | 68 | 17-11-28 |
Jamie Platt
BRD | Director/Board Member | - | Nov. 30 |
Roby Joyce
BRD | Director/Board Member | 76 | 23-09-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,657,537 | 7,622,402 ( 65.39 %) | 0 | 65.39 % |
Company contact information
bioAffinity Technologies, Inc.
22211 West Interstate 10 Suite 1206
78257, San Antonio
+
http://www.bioaffinitytech.comSector
Sales per Business
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+48.25% | 25.41M | |
-2.58% | 8.27B | |
+9.02% | 5.81B | |
+29.76% | 5.58B | |
-15.77% | 3.85B | |
+12.42% | 2.71B | |
-61.85% | 2.56B | |
-7.24% | 2.42B | |
+23.09% | 2.13B | |
-9.25% | 1.77B |
- Stock Market
- Equities
- BIAF Stock
- Company bioAffinity Technologies, Inc.